Cure My Disease

Don't miss your cure!

 Log in / Sign up

New vaccine trial hopes to fight Hard-to-Treat colorectal cancer

NCT ID NCT07510308

Recruiting now Disease control Sponsor: West China Hospital Source: ClinicalTrials.gov ↗

First seen Apr 09, 2026 · Last updated May 24, 2026 · Updated 11 times

Summary

This early-stage trial is testing a new type of cancer vaccine for people with advanced colorectal cancer that hasn't responded to standard treatments. The vaccine is made from the patient's own tumor cells and aims to train the immune system to attack the cancer. The main goal is to check if the vaccine is safe and tolerable, while also looking for any signs that it might shrink tumors or slow the disease.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PMMR/MSS ADVANCED COLORECTAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • West China Hospital, Sichuan University

    RECRUITING

    Chengdu, Sichuan, 610041, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • West China Hospital, Sichuan University

    RECRUITING

    Chengdu, Sichuan, China

Conditions

Explore the condition pages connected to this study.

PMMR/MSS ADVANCED COLORECTAL CANCER